Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Docetaxel and Cisplatin in Advanced NSCLC
NCT00657423Phase 3Unknown
- Sponsor
- Xijing Hospital
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Xijing Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00657423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657423.